Fentanyl Correction | The Medical Letter Inc.

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1036

September 25, 1998

View Complete Issue Table of Contents 2019

Fentanyl Correction

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 1998 Sep 25;40(1036):96

Disclosures

Objective(s)

SUMMARY: In the Medical Letter article Drugs for Pain (vol. 40, page 84, August 14, 1998), the last comment on fentanyl in the table is incorrect. Fentanyl Oralet has not been approved by the FDA for treatment of breakthrough pain.

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.